Index by Author

April 1, 2003; 138 (7)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Al-Sarraf, Muhyi

B

  1. Berl, Tomas

    • Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy Ann Intern Med April 1, 2003 138:542-549

  2. Besser, Richard E.

  3. Boiardi, Luigi

  4. Borrow, Raymond

    • Variation within Genes Encoding Interleukin-1 and the Interleukin-1 Receptor Antagonist Influence the Severity of Meningococcal Disease[dhelix] Ann Intern Med April 1, 2003 138:534-541

  5. Botkin, Jeffrey R.

    • “Genetic Exceptionalism” in Medicine: Clarifying the Differences between Genetic and Nongenetic Tests[dhelix] Ann Intern Med April 1, 2003 138:571-575

  6. Bridges, Carolyn B.

  7. Brodkin, Henry

C

  1. Cannings, Chris

    • Variation within Genes Encoding Interleukin-1 and the Interleukin-1 Receptor Antagonist Influence the Severity of Meningococcal Disease[dhelix] Ann Intern Med April 1, 2003 138:534-541

  2. Chung, Daniel C.

  3. Cooper, Richard S.

    • Genomics and Medicine: Distraction, Incremental Progress, or the Dawn of a New Age?[dhelix] Ann Intern Med April 1, 2003 138:576-580

  4. Crick, F.H.C.

  5. Crowther, Mark A.

D

  1. Demicheli, Vittorio

  2. Drury, Paul L.

    • Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy Ann Intern Med April 1, 2003 138:542-549

  3. Duff, Gordon W.

    • Variation within Genes Encoding Interleukin-1 and the Interleukin-1 Receptor Antagonist Influence the Severity of Meningococcal Disease[dhelix] Ann Intern Med April 1, 2003 138:534-541

E

  1. Esmatjes, Enric

    • Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy Ann Intern Med April 1, 2003 138:542-549

F

  1. for the Clinical Efficacy Assessment Subcommittee of the American College of Physicians*

    • The Evidence Base for Tight Blood Pressure Control in the Management of Type 2 Diabetes Mellitus Ann Intern Med April 1, 2003 138:587-592

  2. for the Collaborative Study Group*

    • Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy Ann Intern Med April 1, 2003 138:542-549

G

  1. Gandjour, Afschin

  2. Ghirarduzzi, Angelo

  3. Goldhaber, Samuel Z.

    • Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy Ann Intern Med April 1, 2003 138:542-549

  4. Gonzales, Ralph

  5. Green, Michael J.

    • “Genetic Exceptionalism” in Medicine: Clarifying the Differences between Genetic and Nongenetic Tests[dhelix] Ann Intern Med April 1, 2003 138:571-575

  6. Gromnica-Ihle, Erika

H

  1. Hayward, Rodney A.

    • Treatment of Hypertension in Type 2 Diabetes Mellitus: Blood Pressure Goals, Choice of Agents, and Setting Priorities in Diabetes Care Ann Intern Med April 1, 2003 138:593-602

  2. Hoagland, Mahlon B.

  3. Hricik, Donald

    • Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy Ann Intern Med April 1, 2003 138:542-549

  4. Hunsicker, Lawrence G.

    • Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy Ann Intern Med April 1, 2003 138:542-549

J

  1. Jefferson, Tom

K

  1. Kaczmarski, Edward B.

    • Variation within Genes Encoding Interleukin-1 and the Interleukin-1 Receptor Antagonist Influence the Severity of Meningococcal Disease[dhelix] Ann Intern Med April 1, 2003 138:534-541

  2. Keeffe, Emmet B.

  3. Kelley, William N.

L

  1. Landefeld, C. Seth

  2. Lee, Patrick Y.

  3. Lewis, Edmund J.

    • Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy Ann Intern Med April 1, 2003 138:542-549

  4. Lewis, Julia B.

    • Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy Ann Intern Med April 1, 2003 138:542-549

  5. Linder, Jeffrey A.

  6. Liu, Margaret A.

  7. Locatelli, Francesco

    • Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy Ann Intern Med April 1, 2003 138:542-549

  8. Long, Heather

M

  1. Maheswaran, Ravi

    • Variation within Genes Encoding Interleukin-1 and the Interleukin-1 Receptor Antagonist Influence the Severity of Meningococcal Disease[dhelix] Ann Intern Med April 1, 2003 138:534-541

  2. Meltzer, Martin I.

  3. Mottur-Pilson, Christel

    • The Evidence Base for Tight Blood Pressure Control in the Management of Type 2 Diabetes Mellitus Ann Intern Med April 1, 2003 138:587-592

N

  1. Naylor, Simone C.

    • Variation within Genes Encoding Interleukin-1 and the Interleukin-1 Receptor Antagonist Influence the Severity of Meningococcal Disease[dhelix] Ann Intern Med April 1, 2003 138:534-541

P

  1. Parikh, Chirag R.

    • Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy Ann Intern Med April 1, 2003 138:542-549

  2. Patel, Amit P.

  3. Peterson, Eric D.

  4. Pfeffer, Marc A.

    • Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy Ann Intern Med April 1, 2003 138:542-549

  5. Porush, Jerome G.

    • Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy Ann Intern Med April 1, 2003 138:542-549

  6. Psaty, Bruce M.

    • Genomics and Medicine: Distraction, Incremental Progress, or the Dawn of a New Age?[dhelix] Ann Intern Med April 1, 2003 138:576-580

R

  1. Raz, Itamar

    • Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy Ann Intern Med April 1, 2003 138:542-549

  2. Read, Robert C.

    • Variation within Genes Encoding Interleukin-1 and the Interleukin-1 Receptor Antagonist Influence the Severity of Meningococcal Disease[dhelix] Ann Intern Med April 1, 2003 138:534-541

  3. Ringstrom, Elin

  4. Rouleau, Jean-Lucien

    • Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy Ann Intern Med April 1, 2003 138:542-549

  5. Rustgi, Anil K.

S

  1. Salvarani, Carlo

  2. Schmidt, Wolfgang A.

  3. Snow, Vincenza

    • The Evidence Base for Tight Blood Pressure Control in the Management of Type 2 Diabetes Mellitus Ann Intern Med April 1, 2003 138:587-592

  4. Srivastava, Indresh K.

  5. Steinman, Michael A.

T

  1. Timms, Janine M.

    • Variation within Genes Encoding Interleukin-1 and the Interleukin-1 Receptor Antagonist Influence the Severity of Meningococcal Disease[dhelix] Ann Intern Med April 1, 2003 138:534-541

V

  1. Vanhille, Philippe

    • Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy Ann Intern Med April 1, 2003 138:542-549

  2. Vijan, Sandeep

    • Treatment of Hypertension in Type 2 Diabetes Mellitus: Blood Pressure Goals, Choice of Agents, and Setting Priorities in Diabetes Care Ann Intern Med April 1, 2003 138:593-602

W

  1. Watson, J.D.

  2. Weideman, Rick

  3. Weiss, Kevin B.

    • The Evidence Base for Tight Blood Pressure Control in the Management of Type 2 Diabetes Mellitus Ann Intern Med April 1, 2003 138:587-592

  4. Wiegmann, Thomas B.

    • Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy Ann Intern Med April 1, 2003 138:542-549

  5. Wolfe, Bernard M.

    • Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy Ann Intern Med April 1, 2003 138:542-549

Current Issue

  1. February 7, 2012, 156 (3)
  1. Alert me to current issues
Most Read Most Read
Most Commented Most Commented On
Annals in the News Annals in the News
Clinical Trials Clinical Trials
Comparative Effectiveness Comparative Effectiveness
Hospital Medicine Hospital Medicine
  • Advertisement
  • Advertisement